Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is now actively participating on the Webull Corporate Communications Service (“CCS”) Platform. Silo Pharma’s portal on the platform provides an additional channel for direct investor communication and audience engagement, even allowing questions and answers. The move also means that Webull’s investor community can access the SILO profile for real-time data and investor communications. “We are excited to share SILO’s new profile on Webull’s Corporate Communications Service Platform and invite investors to take advantage of this convenient and engaging digital communications channel,” said Silo Pharma CEO Eric Weisblum in the press release. “The Webull CCS platform is an additional investor relations tool that magnifies our company’s accessibility and transparency for active retail investors and enables us to share unique content and communicate with them in real time.”
Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as PTSD, Alzheimer’s disease and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research that the company believes will be transformative to the well-being of patients and the healthcare industry. For more information about the company, visit www.SiloPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
D-Wave (NYSE: QBTS), a leader in quantum computing systems, software and services, and Interpublic Group (NYSE: IPG), one of the world’s premier global advertising and marketing services companies, today announced a partnership that will see the companies work together on quantum computing applications that fuel innovation in marketing investments and strategy. D-Wave and IPG will collaborate on the research and development of quantum-hybrid applications designed to address optimization in marketing campaigns.
“In today’s highly connected and deeply digital world, consumers are met with brand messages daily. Breaking through to reach the right customer at the right time remains a difficult challenge given the vast number of variables to consider,” said Dr. Alan Baratz, CEO of D-Wave. “We’re excited to work with IPG to bring the power of quantum to advertising optimization, more efficiently harnessing a massive amount of data to create hyper-targeted campaigns that drive desired outcomes for brands.”
D-Wave is a leader in the development and delivery of quantum computing systems, software and services, and is the world’s first commercial supplier of quantum computers — and the only company building both annealing quantum computers and gate-model quantum computers. The company’s mission is to unlock the power of quantum computing today to benefit business and society. D-Wave does this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.
NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
Mercedes-Benz is seeking to dethrone Tesla as the leading luxury electric vehicle maker. The company is expanding its own charging infrastructure, speeding up the electrification of the fleet and equipping its cars with Level 3 self-driving technologies.
The goal of Mercedes, according to Dimitris Psillakis, is very clear: to emerge as a highly coveted, luxurious electric auto brand. To do this, a balance must be struck between excellent products, fantastic design and helpful service. Psillakis, who is assisting in managing the strong drive toward electric vehicles, stated that the company does not view Tesla as a luxury rival but rather as a disruptive force in the auto industry, particularly with regard to electric cars.
It appears that Mercedes’ approach is registering success. For the first three months of 2023, its sales increased by 251% compared with the same period last year, reaching 7,341 electric vehicles. The company says that in America, 12% of its sales are accounted for by electrical vehicles.
While speaking to ABC News, Jessica Caldwell said that Tesla changed the definition of luxury, yet its share of the market is currently shrinking. The year 2019 marked Tesla’s peak when it commanded 80% of the overall EV market.
At this time, 6% of American car sales are electric vehicles. According to Caldwell, motorists are still hesitant to transition to electric vehicles because of to range anxiety and a lack of accessible charging facilities. Clients are being reassured by Mercedes with outlets for charging, which also serve as an effective marketing tool despite their high cost.
A solution to the nation’s problem of electric vehicle charging could be found in Mercedes’ charging stations, which will debut in the United States and Canada first and are going to be accessible by vehicles made by other manufacturers.
Tesla’s extremely vast network of superchargers and a wide selection of vehicles have earned it a devoted following, according to Tony Quiroga. He said, however, that premium companies such as Mercedes are still in a race for the mass market with Tesla’s Models 3 and Y, although Mercedes may be catching up. He asserted that Mercedes would not lag behind Tesla for long. With its charging infrastructure, Mercedes stands to gain significantly.
Quiroga reported that the two Mercedes electric vehicles — the EQ S580 and the EQ S450+ —outperformed the EPA range tests when put through rigorous 75 mph testing by personnel. A car exceeding its EPA ratings is extremely uncommon, he added.
Mercedes will be in a better position than its rivals due to its momentum in the electric vehicle market. According to Robby Degraff, an Auto Pacific analyst, the company has so far nailed all of the appropriate market groups, from the EQE sedan to the more substantial EQS SUV. This is a strategy and approach that Degraff believes Mercedes-Benz has successfully mastered.
As each vehicle maker, including Mullen Automotive Inc. (NASDAQ: MULN), zeroes in on particular market segments, the race for dominance in the EV space is likely to become more intense.
NOTE TO INVESTORS: The latest news and updates relating to Mullen Automotive Inc. (NASDAQ: MULN) are available in the company’s newsroom at https://ibn.fm/MULN
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.greencarstocks.com/Disclaimer
MULN received an order for one thousand class 3 trucks from its dealer partner, Randy Marion Automotive
The company is excited about entering the next phase of its commercial launch with the Mullen THREE
Mullen inked a $15 million vehicle purchase agreement with the MGT Lease Companyfor 250 class 3 cab chassis EV trucks
On the heels of several purchase agreements and orders, Mullen Automotive (NASDAQ: MULN) is experiencing impressive momentum as it continues to focus on growing in the electric vehicle space. Most recently, the company received a 1,000-unit purchase order (https://ibn.fm/2tLyU) and announced a $15.7 million vehicle purchase order with a lease company, both for its Mullen THREE class 3 truck (https://ibn.fm/y31v4).
The order for one thousand class 3 trucks came from Mullen’s dealer partner, Randy Marion Automotive, which earlier this month received the first class 3 demonstration vehicle for customer test drives and demonstrations. “Based on the tremendous interest we received on the Mullen class 3 truck, we placed our 1,000-vehicle order,” said Brad Sigmon, the fleet general manager and vice president of Randy Marion Automotive fleet operations. “We have a lineup of our customers waiting to pilot this truck including Duke Energy, Lowes and UNC-Charlotte.”
Mullen has announced that the class 3 truck will be priced at $68,500 and includes an estimated 130-mile range along with a 5,800-pound payload and capability of carrying a 14-foot box with more than 1,000 cubic feet of cargo capacity.
Mullen chief commercial officer John Schwegman noted that the company is excited about entering the next phase of its commercial launch with the Mullen THREE, which he identified as “the customers, piloting, testing and evaluation stage. Demand has been strong since we introduced this product and the aggressive price point. We are excited to get customers behind the wheel of our class 3 product.”
In addition, Mullen signed a vehicle purchase agreement, valued at more than $15.7 million, with MGT Lease Company,for 250 class 3 cab chassis EV trucks. According to the agreement, Mullen will begin delivering the first of the trucks in August 2023, with all vehicles being delivered by the end of the year.
A growing commercial vehicle sales and leasing company based in North Carolina, MGT is focused on a customer base that is looking for last-mile delivery solutions, such as package delivery and retail, along with vocations such as plumbing and electrical. MGT has ordered the all-electric class 3 EV cab chassis trucks for addition to its short- and long-term fleet leasing portfolio. MGT has worked with Mullen before; the company initially purchased EV cargo vans earlier this year. “We are very happy with the Mullen EV cargo van and have received great customer feedback and are now looking forward to expanding into Mullen’s commercial class 3 truck,” said Greg Striker, a partner at MGT Lease Co.
Mullen Automotive (NASDAQ: MULN) is a Southern California-based automotive company building the next generation of electric vehicles (“EVs”) that will be manufactured in its two United States-based assembly plants. Mullen’s EV development portfolio includes the Mullen FIVE EV Crossover, Mullen-GO Commercial Urban Delivery EV, Mullen Commercial Class 1-3 EVs and Bollinger Motors, which features both the B1 and B2 electric SUV trucks and Class 4-6 commercial offerings. On Sept. 7, 2022, Bollinger Motors became a majority-owned EV truck company of Mullen Automotive, and on Dec. 1, 2022, Mullen closed on the acquisition of all of Electric Last Mile Solutions’ (“ELMS”) assets, including all IP and a 650,000-square-foot plant in Mishawaka, Indiana.
NOTE TO INVESTORS: The latest news and updates relating to MULN are available in the company’s newsroom at https://ibn.fm/MULN
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 844-397-5787 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.greencarstocks.com/Disclaimer
ABM (NYSE: ABM) Hosts Robot Roadshow at Two Major Industry Conferences
Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”), a leading developer of autonomous security robots and blue light emergency communication systems, today announced that it received a new contract for 13 K1 Blue Light E-Phones from Texas State University (“TXST”).
Texas State University Signs Contract for 13 Emergency Communication Devices (Photo: Knightscope)
For students, parents, administrators and faculty, safety on campus is always a top concern. Although it’s common to think of a cell phone as the easiest solution for calling for help in an emergency, there are countless times when mobile communications fail due to a lack of cellular service, a device that gets lost or runs out of battery, or even acceptable use policies on campus. Knightscope’s emergency communication systems ensure a one-touch, 24/7 connection to public safety officials on campus.
TXST is a public institution that was founded in 1899 that currently has more than 38,000 undergraduate and graduate students. TXST is the 4th largest public university in Texas, and Knightscope is proud to be chosen as its provider for these critical, and sometimes lifesaving, lines of communication.
To learn more about Knightscope’s Autonomous Security Robots and Blue Light Emergency Communication Systems, book a discovery call or demonstration now at www.knightscope.com/discover .
In Case You Missed It: ABM (NYSE: ABM) will Host Robot Roadshow at Two Major Conferences
ABM is hosting the Robot Roadshow at two annual industry conferences in June: the American Association of Airport Executives from June 3-5 in Denver, CO, and the IPMI Parking & Mobility Conference from June 12-14 in Fort Worth, TX. Hours vary so please check the schedule for more details or to book your visit.
The Robot Roadshow is an engaging experiential event used to grab attention fast, forge direct connections with potential clients, and strike up conversations about these exciting technologies in a compelling fashion. Demonstrations are conducted by Knightscope experts and take place in a climate controlled, space-age “pod” allowing attendees to experience the technologies that are helping make sites safer today from Hawaii to Texas to Pennsylvania. Visitors will be able to interact directly with Autonomous Security Robots, test a blue light emergency phone, and see the Knightscope Security Operations Center (KSOC) user interface in action. Clients, investors and the media are all welcome to attend to learn more.
The Robot Roadshow will be located just outside the convention center of each event and there is no charge to participate. Available slots fill up fast, so book your Pod visit here to get one-on-one attention.
About Knightscope
Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. Learn more about us at www.knightscope.com . Follow Knightscope on Facebook , Twitter , LinkedIn and Instagram .
Forward-Looking Statements
This press release may contain “forward-looking statements” about Knightscope’s future expectations, plans, outlook, projections and prospects. Such forward-looking statements can be identified by the use of words such as “should,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” “proposes” and similar expressions. Forward-looking statements contained in this press release include, but are not limited to, statements about the Company’s path to profitability, the Company’s targeted annualized revenue run rate, the Company’s plans for top-line growth, the Company’s ability to deliver on its backlog of new orders, the benefits of the Company’s planned streamlining of its operations and rightsizing of its combined workforce and the Company’s ability to achieve improved margins. Although Knightscope believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. These risks and uncertainties include, among other things, the risk that the restructuring costs and charges may be greater than anticipated; the risk that the Company’s restructuring efforts may adversely affect the Company’s internal programs and the Company’s ability to recruit and retain skilled and motivated personnel, and may be distracting to employees and management; the risk that the Company’s restructuring efforts may negatively impact the Company’s business operations and reputation with or ability to serve customers; the risk that the Company’s restructuring efforts may not generate their intended benefits to the extent or as quickly as anticipated. Readers are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” in Knightscope’s Annual Report on Form 10-K for the year ended December 31, 2022. Forward-looking statements speak only as of the date of the document in which they are contained, and Knightscope does not undertake any duty to update any forward-looking statements, except as may be required by law.
The coronavirus pandemic threw the entire world into a lurch and showed us just how difficult it can be to deal with a pandemic in our increasingly connected world. A few months after the virus was first discovered in Wuhan, China, dozens of countries shut down their borders to stop the disease from spreading at the cost of economic activity.
The coronavirus vaccine appears to have been instrumental in stopping COVID-19 infections, reducing negative health outcomes and opening up the world to international activity once again. However, although we are now through the worst of the pandemic, infections are still common and plenty of people currently deal with the symptoms of long COVID.
In fact, there have been several anecdotal reports of some people developing tinnitus after being vaccinated against the communicable disease. Tinnitus is a condition that causes patients to hear a high-pitched ringing sound or other sounds in one or both of their ears. It occurs with much more frequency in older people and affects around 15% to 20% of the population.
These anecdotal reports point to one of the COVID-19 vaccines as a possible cause for developing tinnitus. These reports may have some validity because other types of vaccines, such as the flu shot, are also thought to contribute to tinnitus by triggering an inflammatory response in patients. However, the Centers for Disease Control and Prevention (CDC) states that there is currently no evidence tying coronavirus vaccines to the development of tinnitus.
The University of California’s director of otology, neurology and skull base surgery Dr. Hamid. R Djalilian explains that it is currently unclear whether the COVID-19 vaccine triggers an inflammatory response in the body or whether there was simply an overlap between people with tinnitus and people who received the coronavirus vaccine.
Although research on the link between the COVID-19 vaccines and tinnitus is still scant, the amount of anecdotal reports on the connection warrant further research into the matter. A March 2022 report revealed that up to 12,247 people had reported developing tinnitus after receiving a COVID-19 vaccine. A different study from the same year listed tinnitus as one of the most common otolaryngology side effects in patients who received the COVID-19 vaccination.
A more recent paper from March 2023 stated that although the occurrence of tinnitus after COVID-19 vaccination is indeed rare, there are some cases where patients can develop severe tinnitus after vaccination. Yale Medicine infectious disease specialist Dr. Scott Roberts says that the CDC is currently investigating these reports to determine if there is an association between tinnitus and COVID-19 vaccines.
For those found to have developed tinnitus as a result of receiving the COVID jab, possible remedies from Jupiter Wellness Inc. (NASDAQ: JUPW) and other biotech companies are available to help in addressing the condition.
NOTE TO INVESTORS: The latest news and updates relating to Jupiter Wellness Inc. (NASDAQ: JUPW) are available in the company’s newsroom at https://ibn.fm/JUPW
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Smart organizations are encouraged to meet certain standards and regulations to protect data against cybersecurity threats
With more than 15 billion user credentials scattered across the dark web, the threat is real
CEO notes that compliance is an important driver for security, and organizations should never view it as a mere technical nuisance
Complying with security requirements should be about more than just ticking off mandatory checkboxes, says CISO Global (NASDAQ: CISO) CEO David Jemmett (https://ibn.fm/dDN38). CISO Global, formerly Cerberus Cyber Sentinel Corp., works closely with companies to provide essential protection, and Jemmett is a recognized expert in the field of cybersecurity.
“Today, all organizations are required or encouraged to meet certain standards and regulations to protect their data against cybersecurity threats,” writes Jemmett in a guest essay for The Last Watchdog. “The regulations vary across countries and industries, but they are designed to protect customers from the threat of posed data breaches.”
That threat is real, notes Jemmett, citing estimates that currently more than 15 billion user credentials are scattered across the dark web. “The importance of compliance is clear to see,” he writes. “In spite of this, many organizations today still see compliance as a nuisance, rather than a business enabler. All too often, organizations will analyze compliance requirements and harden their systems and practices to meet them, without really thinking about their importance to the business. Instead, they will tick the mandatory checkboxes, even if security measures haven’t been enacted, and file the record away as quickly as possible.”
This approach is dangerous, explains Jemmett, noting that single “point-in-time” compliance doesn’t cut it in today’s threat landscape. “Compliance is no longer a ‘set and forget’ security framework,” he continues. “To keep up to speed in today’s evolving threat landscape, compliance is a process that must be maintained continuously.”
In his essay, Jemmett offers several tips to help companies implement an effective cybersecurity compliance strategy, providing timely, relevant protection against current as well as new and emerging threats. These suggestions include staying up-to-date with the evolving and growing attack surface, taking a risk-based approach and remembering that cybersecurity is a culture, not a product. “Compliance is an important driver for security, and organizations should never view it as a mere technical nuisance. Cybersecurity is a critical business enabler today, and those that get it right will excel. Those that get it wrong, and do not prioritize their defenses, could stand to lose everything,” Jemmett concluded.
CISO Global is gaining recognition as a leading provider of global cybersecurity and compliance as it rapidly expands by acquiring world-class cybersecurity, secured-managed services and compliance companies. These acquisitions bring top-tier talent to the CISO table, enabling the company to utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations, mitigating continuing and emerging security threats and compliance obligations.
For more information, visit the company’s website at www.CISO.inc.
NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO
About TechMediaWire
TechMediaWire (“TMW”) is a tech-focused financial news and content distribution company, one of 50+ brands within IBN, providing: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a specialized communications platform with an extensive team of contributing journalists and writers, TMW is uniquely positioned to best serve private and public tech companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By putting a spotlight on the latest and greatest in the tech industry, TMW brings its clients unparalleled visibility, recognition and brand awareness. TMW is where investors come to learn about the next big things in tech and the companies that are making them happen.
To receive SMS text alerts from TechMediaWire, text “TECH” to 844-397-5787 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the TechMediaWire website applicable to all content provided by TMW, wherever published or re-published: https://TechMediaWire.com/disclaimer
Biotechnology innovator BiondVax Pharmaceuticals is dedicated to developing nanosized antibody (NanoAb) treatment
BiondVax is also leveraging its team experience in preclinical stage to Phase 3 clinical trial product development to generate new revenues by offering cGMP contract development and manufacturing organization (“CDMO”) services
The company recently exhibited its CDMO expertise as well as its NanoAb development pipeline at the 21st annual Biomed Israel conference, which drew over 6,000 attendees from a wide variety of international life sciences disciplines
BiondVax’s NanoAb drug candidate pipeline has expanded focus on immune system cytokine targets for treating psoriasis and psoriatic arthritis
Israel-based biotechnology company BiondVax Pharmaceuticals (NASDAQ: BVXV) is building on positive preclinical data regarding its innovative inhaled anti-SARS-CoV-2 nanosized antibody (NanoAb) product with plans to develop further NanoAbs targeting immune system cytokines while the company expands its frontiers by beginning to offer contract development and manufacturing organization (“CDMO”) services.
BiondVax showcased its CDMO services and expertise at the premier conference for international Life Science and HealthTech industries earlier this month in Israel. The 21st annual Biomed Israel drew more than 6,000 industry leaders, scientists, engineers, physicians, and investors from over 45 countries, providing BiondVax a worldwide stage for exhibiting its potential blockbuster products and state-of-the-art assets and services.
“Senior executives and delegations from multinationals, big pharma, medical devices, tech giants and international investors in the health industry come to Israel each May to ‘shop for’ innovation in the field, in search of creative solutions, products and technologies, and the next big thing,” Biomed Israel Co-chairwoman Ruti Alon stated in a news release about the event (https://ibn.fm/jWiGl).
BiondVax has gained significant expertise in developing and producing current good manufacturing practice (“cGMP”) compliant drug candidates, working from preclinical stage to Phase 3 clinical trials. Making its cGMP manufacturing facility available for the development of other companies’ products helps to advance the potential of improving medical therapies and responding to unmet medical needs.
The company’s CDMO services include aseptic filling, upstream and downstream process development, as well as analytical model development. BiondVax is contracting its suite of boutique end-to-end services (https://ibn.fm/ArbDX) to large pharmaceutical and biotech companies, alternative protein food tech companies, and smaller development-stage companies in general.
Offering CDMO services “allows us to use our state-of-the-art facility to generate revenues and offset certain fixed costs while still using it for our NanoAbs,” CEO Amir Reichman stated in a year-end letter to shareholders (https://ibn.fm/FRmQg).
“The team already knows how to work together. The team has experience with running pre-clinical trials, clinical trials, chemistry, manufacturing and controls [CMC], quality assistance — everything works; it’s an oiled machine. Also the capacity and the capabilities are there,” Reichman said in a March interview with Digital Niche Agency that addressed BiondVax’s efforts to strengthen its value for its shareholders (https://ibn.fm/IAcxF).
A recent statement on the company’s quarterly financial results noted that the company has begun R&D activities for the innovative NanoAb platform targeting immune system cytokines. The drug candidate development process will focus on cytokines such as IL-17 for their potential in treating psoriasis and psoriatic arthritis, both large market disorders with large unmet medical needs.
For more information, visit the company’s website at www.BiondVax.com.
NOTE TO INVESTORS: The latest news and updates relating to BVXV are available in the company’s newsroom at https://ibn.fm/BVXV
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
D-Wave Quantum Inc. (NYSE: QBTS), a leader in quantum computing systems, software and services, and Interpublic Group (NYSE: IPG), one of the world’s premier global advertising and marketing services companies, today announced a partnership that will see the companies work together on quantum computing applications that fuel innovation in marketing investments and strategy.
D-Wave and IPG will collaborate on the research and development of quantum-hybrid applications designed to address optimization in marketing campaigns. Together, the companies will use D-Wave’s quantum computers and hybrid solvers, accessible through the Leap™ quantum cloud service, coupled with IPG’s own data assets, to create quantum applications geared to building high-value audiences for marketers in a variety of settings. IPG recently launched a pilot program with D-Wave to build marketing optimization equations for one of the company’s top 20 clients to optimize campaigns in a retail environment.
“At IPG, we understand that every customer is unique, with very personal passions, behaviors and motivations,” said Philippe Krakowsky, CEO of IPG. “By working with D-Wave and adopting quantum technology as part of our tech stack, we believe we can uncover an even greater collection of data-driven insights to deliver more relevant and effective marketing for our clients, at scale.”
“In today’s highly connected and deeply digital world, consumers are met with brand messages daily. Breaking through to reach the right customer at the right time remains a difficult challenge given the vast number of variables to consider,” said Dr. Alan Baratz, CEO of D-Wave. “We’re excited to work with IPG to bring the power of quantum to advertising optimization, more efficiently harnessing a massive amount of data to create hyper-targeted campaigns that drive desired outcomes for brands.”
About D-Wave Quantum Inc.
D-Wave is a leader in the development and delivery of quantum computing systems, software, and services, and is the world’s first commercial supplier of quantum computers—and the only company building both annealing quantum computers and gate-model quantum computers. Our mission is to unlock the power of quantum computing today to benefit business and society. We do this by delivering customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. D-Wave’s technology is being used by some of the world’s most advanced organizations, including Volkswagen, Mastercard, Deloitte, Davidson Technologies, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, Forschungszentrum Jülich, University of Southern California, and Los Alamos National Laboratory.
About Interpublic
Interpublic (NYSE: IPG) (www.interpublic.com) is a values-based, data-fueled, and creatively-driven provider of marketing solutions. Home to some of the world’s best-known and most innovative communications specialists, IPG global brands include Acxiom, Craft, FCB, FutureBrand, Golin, Huge, Initiative, IPG Health, Jack Morton, Kinesso, MAGNA, Matterkind, McCann, Mediabrands, Mediahub, Momentum, MRM, MullenLowe Group, Octagon, R/GA, UM, Weber Shandwick and more. IPG is an S&P 500 company with total revenue of $10.93 billion in 2022.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: “may,” “will,” “could,” “would,” “should,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,” “continue,” “ongoing,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. These statements involve risks, uncertainties, and other factors that may cause actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward-looking statements. We caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, which are subject to a number of risks. Forward-looking statements in this press release include, but are not limited to, statements regarding the collaboration between D-Wave and IPG and the potential results of this collaboration. We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including general economic conditions and other risks, our ability to expand our customer base and the customer adoption of our solutions, and the uncertainties and factors set forth in the sections entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022, as well as factors associated with companies, such as D-Wave, that are engaged in the business of quantum computing, including anticipated trends, growth rates, and challenges in those businesses and in the markets in which they operate; the outcome of any legal proceedings that may be instituted against us; risks related to the performance of our business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and or timing thereof; the performance of the our products; the effects of competition on our business; the risk that we will need to raise additional capital to execute our business plan, which may not be available on acceptable terms or at all; the risk that we may never achieve or sustain profitability; the risk that we are unable to secure or protect our intellectual property; volatility in the price of our securities; and the risk that our securities will not maintain the listing on the NYSE. Furthermore, if the forward-looking statements contained in this press release prove to be inaccurate, the inaccuracy may be material. In addition, you are cautioned that past performance may not be indicative of future results. In light of the significant uncertainties in these forward-looking statements, you should not place undue reliance on these statements in making an investment decision or regard these statements as a representation or warranty by any person we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.
Friday, June 2nd, 2023NewsComments Off on $QBTS $IPG D-Wave and Interpublic Group Partner on Quantum-Powered Advertising Optimization
Flora Growth Corp. (NASDAQ: FLGC), a cannabis cultivator and global distributor, is a rapidly growing house of brands building customer bases and distribution channels across international lines as it aims to distinguish itself within a highly competitive arena. “Much of Flora Growth’s strength lies in its licensed cultivation, extraction and isolation facility located in northern Colombia’s fertile climate, where an experienced labor force is helping the nation emerge from decades of drug war illicit trade into a recognized and regulated market,” a recent article reads. “From its 247 acres of growing fields, the company’s harvests move into a production pipeline that includes a flower and derivatives production lab situated within the cultivation camp, as well as a topical, capsules and dietary supplements lab in Colombia’s capital and a third lab in the United States, where CBD ingestible, tinctures and gummies are made. A fourth state-of-the-art lab being built in Colombia’s capital is being designed to formulate custom and proprietary pharmaceuticals that will be sold and used in Colombia. The life sciences lab is expected to open by the end of this year with eight registered pharmaceutical grade formulas that target specific ailments such as insomnia, epilepsy and anxiety.”
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands, designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its commercial, house of brands and life sciences divisions. Visit www.FloraGrowth.com or follow @floragrowthcorp on social media for more information.
NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
Monday, January 9th, 2023NewsComments Off on $FLGC CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Leveraging Colombia, US Facilities to Distinguish Itself Within Highly Competitive Space
Texas State University Signs Contract for 13 Emergency Communication Devices (Photo: Knightscope)